Jan. 12, 2023—A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.
Children’s Hospital patients get creative for Vanderbilt Men’s Basketball team as part of Coaches vs. Cancer
Feb. 3, 2022—by Christina Echegaray Ariana Robinson, 14, loves family and animals, appreciates the vibrancy of life and believes in hard work. Logan Hall, 13, is an avid sports fan and athlete and is passionate about a good motivational speech from his coaches before a football or baseball game. Both Ariana and Logan have acute myeloid leukemia...
Sep. 24, 2020—Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
New cutting-edge treatment for type of pediatric leukemia offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt
Sep. 18, 2017—Monroe Carell Jr. Children’s Hospital at Vanderbilt is part of a select group of health care institutions recently chosen to offer a new FDA-approved immunotherapy for a subset of pediatric acute lymphoblastic leukemia (ALL). Only 32 health care institutions in the United States will be certified to offer the therapy. Vanderbilt is only one of...